SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancerJin Li, Shukui Qin, Zhendong Chen et al.|Cancer Immunology Immunotherapy|2024Cited by 15
RORα overexpression reduced interleukin‐33 expression and prevented mast cell degranulation and inflammation by inducing autophagy in allergic rhinitisWangbo Yu, Tao Zhang|Immunity Inflammation and Disease|2023Cited by 7